Elanco Animal Health (ELAN) Competitors

BioNTech (NASDAQ:BNTX) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, community ranking, valuation, institutional ownership, analyst recommendations and media sentiment.

Which has more risk & volatility, BNTX or ELAN?

BioNTech has a beta of 0.26, meaning that its share price is 74% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500.

Does the media prefer BNTX or ELAN?

In the previous week, BioNTech had 5 more articles in the media than Elanco Animal Health. MarketBeat recorded 35 mentions for BioNTech and 30 mentions for Elanco Animal Health. BioNTech's average media sentiment score of 0.31 beat Elanco Animal Health's score of 0.03 indicating that BioNTech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioNTech	5 Very Positive mention(s)	5 Positive mention(s)	15 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
Elanco Animal Health	2 Very Positive mention(s)	0 Positive mention(s)	27 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts prefer BNTX or ELAN?

BioNTech currently has a consensus price target of $138.79, suggesting a potential upside of 35.88%. Elanco Animal Health has a consensus price target of $17.14, suggesting a potential upside of 27.55%. Given BioNTech's stronger consensus rating and higher possible upside, analysts plainly believe BioNTech is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioNTech	0 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.81
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Does the MarketBeat Community prefer BNTX or ELAN?

BioNTech and Elanco Animal Health both received 136 outperform votes by MarketBeat users. However, 54.62% of users gave Elanco Animal Health an outperform vote while only 45.48% of users gave BioNTech an outperform vote.

Company	Underperform	Outperform
BioNTech	Outperform Votes 136 45.48%	Underperform Votes 163 54.52%
Elanco Animal Health	Outperform Votes 136 54.62%	Underperform Votes 113 45.38%

Is BNTX or ELAN more profitable?

Elanco Animal Health has a net margin of 4.60% compared to BioNTech's net margin of -15.16%. Elanco Animal Health's return on equity of 6.78% beat BioNTech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioNTech	-15.16%	-2.35%	-2.05%
Elanco Animal Health	4.60%	6.78%	3.03%

Which has higher valuation & earnings, BNTX or ELAN?

BioNTech has higher earnings, but lower revenue than Elanco Animal Health. BioNTech is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioNTech	$3.04B	8.05	$1.01B	-$2.10	-48.64
Elanco Animal Health	$4.42B	1.50	-$1.23B	$0.40	33.60

Do institutionals and insiders hold more shares of BNTX or ELAN?

15.5% of BioNTech shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 19.2% of BioNTech shares are held by insiders. Comparatively, 0.6% of Elanco Animal Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

BioNTech and Elanco Animal Health tied by winning 9 of the 18 factors compared between the two stocks.